20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Procuring Olaparib (CAS 763113-22-0): A Guide for Pharmaceutical Buyers

For procurement professionals in the pharmaceutical industry, sourcing key intermediates like Olaparib (CAS 763113-22-0) requires a strategic approach. As a leading manufacturer and supplier of high-quality pharmaceutical materials, we understand the critical factors that drive purchasing decisions for compounds essential to cancer research and drug development.

Olaparib, a potent PARP inhibitor, is highly sought after for its role in treating various cancers, particularly those with specific genetic mutations like BRCA. Its mechanism of action, targeting DNA repair pathways in cancer cells, makes it a cornerstone in the development of advanced oncological therapies. When you need to purchase Olaparib, ensuring its purity, consistency, and availability is paramount.

As a dedicated Olaparib supplier based in China, we specialize in providing pharmaceutical-grade materials that meet stringent international quality standards. Our manufacturing processes are designed to yield Olaparib with a purity exceeding 99%, crucial for applications ranging from early-stage research to late-stage clinical trials. We cater to both small-scale research needs and large-volume bulk orders, ensuring a reliable supply chain for our clients worldwide.

When evaluating potential suppliers, consider factors beyond just price. A reliable manufacturer will offer comprehensive documentation, including Certificates of Analysis (CoA) and detailed specifications, confirming the quality and identity of the Olaparib. Furthermore, a robust supply chain managed by an experienced manufacturer is key to preventing disruptions in your research or production timelines. We are committed to transparency and customer support, aiming to be more than just a supplier, but a partner in your development process.

For pharmaceutical companies and contract research organizations (CROs) looking to secure a consistent and high-quality source of Olaparib, engaging with an established manufacturer is the most effective strategy. We invite you to request a quote for bulk purchases or discuss your specific requirements for Olaparib. Partner with us to ensure the success of your oncology-focused pharmaceutical projects.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Olaparib: Understanding the PARP Inhibitor for Advanced Cancer Therapies

Next: Olaparib: Mechanism, Applications, and Supply Chain for Researchers

All Rights Reserved